Incyte Corporation (INCY) Financials
INCY Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 6.8 billion | 1.6 billion |
2023-09-30 | 6.4 billion | 1.5 billion |
2023-06-30 | 6.2 billion | 1.5 billion |
2023-03-31 | 5.8 billion | 1.3 billion |
INCY Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | 145.5 million | 60.0 million |
2023-09-30 | 136.9 million | 48.0 million |
2023-06-30 | 299.2 million | 54.5 million |
2023-03-31 | -132.5 million | 53.4 million |
INCY Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2023-12-31 | 201.1 million |
2023-09-30 | 171.3 million |
2023-06-30 | 203.5 million |
2023-03-31 | 21.7 million |
INCY Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 3.7 billion | - | 38.3 million |
2023-09-30 | 3.5 billion | - | 31.9 million |
2023-06-30 | 3.4 billion | - | 39.7 million |
2023-03-31 | 3.1 billion | - | 32.8 million |
INCY Shares Outstanding
INCY Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | 2.3 million | 444.5 million | 293.9 million | - |
2023-09-30 | 11.0 million | 375.7 million | 267.9 million | 7000 |
2023-06-30 | 7.3 million | 400.8 million | 283.9 million | - |
2023-03-31 | 26.9 million | 406.6 million | 315.6 million | 6000 |
INCY Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 1.0 billion | 69.8 million |
2023-09-30 | 919.0 million | 60.1 million |
2023-06-30 | 954.6 million | 68.3 million |
2023-03-31 | 808.7 million | 56.8 million |
INCY
Price: $53.09
52 week price:
Earnings Per Share: 2.65 USD
P/E Ratio: 30.67
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 1.0 million
Ebitda: -135.0 millionMarket Capitalization: 12.4 billion